Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE) - PubMed (original) (raw)
Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE)
M Penkowa et al. Exp Neurol. 2001 Jul.
Abstract
Experimental autoimmune encephalomyelitis (EAE) is an animal model for the human autoimmune disease multiple sclerosis (MS). Proinflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) are considered important for induction and pathogenesis of EAE/MS disease, which is characterized by significant inflammation and neuroglial damage. We have recently shown that the exogenous administration of the antioxidant protein zinc-metallothionein-II (Zn-MT-II) significantly decreased the clinical symptoms, mortality, and leukocyte infiltration of the CNS during EAE. However, it is not known how EAE progression is regulated nor how cytokine production and cell death can be reduced. We herewith demonstrate that treatment with Zn-MT-II significantly decreased the CNS expression of IL-6 and TNF-alpha during EAE. Zn-MT-II treatment could also significantly reduce apoptotic cell death of neurons and oligodendrocytes during EAE, as judged by using TUNEL and immunoreactivity for cytochrome c and caspases 1 and 3. In contrast, the number of apoptotic lymphocytes and macrophages was less affected by Zn-MT-II treatment. The Zn-MT-II-induced decrease in proinflammatory cytokines and apoptosis during EAE could contribute to the reported diminution of clinical symptoms and mortality in EAE-immunized rats receiving Zn-MT-II treatment. Our results demonstrate that MT-II reduces the CNS expression of proinflammatory cytokines and the number of apoptotic neurons during EAE in vivo and that MT-II might be a potentially useful factor for treatment of EAE/MS.
Copyright 2001 Academic Press.
Similar articles
- Involvement of Src-suppressed C kinase substrate in experimental autoimmune encephalomyelitis: a link between release of astrocyte proinflammatory factor and oligodendrocyte apoptosis.
Li X, Yan M, Hu L, Sun L, Zhang F, Ji H, Jiang J, Wang P, Liu H, Gao Y, Tao T, He X, Cheng C, Shen A. Li X, et al. J Neurosci Res. 2010 Jul;88(9):1858-71. doi: 10.1002/jnr.22355. J Neurosci Res. 2010. PMID: 20155814 - Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
Weishaupt A, Kuhlmann T, Schönrock LM, Toyka KV, Brück W, Gold R. Weishaupt A, et al. Acta Neuropathol. 2002 Oct;104(4):385-90. doi: 10.1007/s00401-002-0568-y. Epub 2002 May 23. Acta Neuropathol. 2002. PMID: 12200625 - Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M, Camats J, Hadberg H, Quintana A, Rojas S, Giralt M, Molinero A, Campbell IL, Hidalgo J. Penkowa M, et al. J Neurosci Res. 2003 Aug 15;73(4):481-96. doi: 10.1002/jnr.10681. J Neurosci Res. 2003. PMID: 12898533 - [The role of apoptosis in autoimmune encephalomyelitis].
Okuda Y, Sakoda S. Okuda Y, et al. Nihon Rinsho. 2003 Aug;61(8):1323-8. Nihon Rinsho. 2003. PMID: 12962018 Review. Japanese. - Tumor Necrosis Factor and Interleukin-1_β_ Modulate Synaptic Plasticity during Neuroinflammation.
Rizzo FR, Musella A, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Mandolesi G, Centonze D, Gentile A. Rizzo FR, et al. Neural Plast. 2018 May 14;2018:8430123. doi: 10.1155/2018/8430123. eCollection 2018. Neural Plast. 2018. PMID: 29861718 Free PMC article. Review.
Cited by
- Metallothionein 1: A New Spotlight on Inflammatory Diseases.
Dai H, Wang L, Li L, Huang Z, Ye L. Dai H, et al. Front Immunol. 2021 Nov 5;12:739918. doi: 10.3389/fimmu.2021.739918. eCollection 2021. Front Immunol. 2021. PMID: 34804020 Free PMC article. Review. - The nitroxide 4-methoxy-tempo inhibits the pathogenesis of dextran sodium sulfate-stimulated experimental colitis.
Chami B, San Gabriel PT, Kum-Jew S, Wang X, Dickerhof N, Dennis JM, Witting PK. Chami B, et al. Redox Biol. 2020 Jan;28:101333. doi: 10.1016/j.redox.2019.101333. Epub 2019 Sep 28. Redox Biol. 2020. PMID: 31593888 Free PMC article. - Metallothionein-I + II Reduces Oxidative Damage and Apoptosis after Traumatic Spinal Cord Injury in Rats.
Rios C, Santander I, Méndez-Armenta M, Nava-Ruiz C, Orozco-Suárez S, Islas M, Barón-Flores V, Diaz-Ruiz A. Rios C, et al. Oxid Med Cell Longev. 2018 Nov 5;2018:3265918. doi: 10.1155/2018/3265918. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30524652 Free PMC article. - Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn's disease patients.
Greuter T, Franc Y, Kaelin M, Schoepfer AM, Schreiner P, Zeitz J, Scharl M, Misselwitz B, Straumann A, Vavricka SR, Rogler G, von Känel R, Biedermann L. Greuter T, et al. Therap Adv Gastroenterol. 2018 Feb 19;11:1756283X18757715. doi: 10.1177/1756283X18757715. eCollection 2018. Therap Adv Gastroenterol. 2018. PMID: 29487628 Free PMC article. - Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice.
Pentón-Rol G, Lagumersindez-Denis N, Muzio L, Bergami A, Furlan R, Fernández-Massó JR, Nazabal-Galvez M, Llópiz-Arzuaga A, Herrera-Rolo T, Veliz-Rodriguez T, Polentarutti N, Marín-Prida J, Raíces-Cruz I, Valenzuela-Silva C, Teixeira MM, Pentón-Arias E. Pentón-Rol G, et al. J Neuroimmune Pharmacol. 2016 Mar;11(1):153-67. doi: 10.1007/s11481-015-9642-9. Epub 2015 Nov 10. J Neuroimmune Pharmacol. 2016. PMID: 26556034
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources